Starting on:
Oct 4, 2022
Ending on:
Nov 10, 2022
Moderator(s):
Venue:
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Oct 4, 2022
Ending on:
Nov 10, 2022
Moderator(s):
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Colorectal Cancer Preceptorship (CRP 103)
Starting on:
Oct 4, 2022 4:00 PM
Oct 4, 2022 4:00 PM
Ending on:
Nov 10, 2022 5:30 PM
Nov 10, 2022 5:30 PM
Venue:
Virtual-ICI
Virtual-ICI
Description
International Cancer Instituteâ??s Preceptorship Courses aim to leverage the expertise of its Faculty to help clinicians understand best practices in the diagnosis and management of conditions encountered in the clinical setting in sub-Saharan Africa.
Objectives
At the end of this educational activity, participants should be able: 1. To understand the Epidemiology of Colorectal Cancer (Global) 2. To understand colorectal cancer prevention and evidence-based screening guidelines 3. To learn the diagnostics, biological basis, prognostic factors, and characterization of colon and rectal cancers, understanding the different biological and pathological subtypes of colon and rectal cancer for the selection of appropriate treatment strategies 4. To understand the role of Surgery in the management of colon and rectal cancer 5. To understand that colon and rectal cancer in early stages are treated differently 6. Evaluate the role of neoadjuvant care, radiotherapy, and chemotherapy in rectal cancer py and chemotherapy in the neoadjuvant setting and mitigation measures. 7. To understand the essentials in the assessment and the value of multidisciplinary management of patients with CRC. 8. To understand the role of chemotherapy, monoclonal antibodies, and targeted therapy in the management of patients with advanced disease and standard of care protocols. 9. To be knowledgeable about the strengths of, and role of personalized medicine and the importance of offering individualized targeted therapies based on molecular findings such as K-Ras, N-Ras, or B-Raf mutations 10. To be knowledgeable on colorectal cancer-related hereditary syndromes, the management of families with these, and implications for individual patients 11. To understand the role of Palliative, supportive, and survivorship care in colorectal cancer management 12. To discuss the role and integration of Biosimilars in Colorectal Cancer management 13. Appreciate the research priority areas in Colorectal cancer in SSA
Presenters
-
Dr.
Abdu Yesufe
Clinical Oncologist
St. Paul's Millenium Hospital, Ethiopia -
Dr.
Clifford Chacha
General Surgeon
Gatundu Level 5 Hospital -
Dr.
David Wata
Pharmacist
Kenyatta National Hospital -
Dr.
Kibet Kibor
Pathologist
Moi Teaching and Referral Hospital -
Dr.
Jabulani Munalula
Surgeon
Medland Health Services Zambia -
Dr.
Zipporah Ali
Palliative Care Specialist
Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA). -
Dr.
Helena Musau
Clinical Oncologist
Meru Teaching and Referral Hospital -
Dr.
Sitna Mwanzi
Medical Oncologist
Aga Khan University Hospital -
Prof.
Dinesh Pendharkar
Medical Oncologist
Sarvodaya Hospital Faridabad,Delhi -
Dr.
Kevin Makori
Clinical and Radiation Oncologist
International Cancer Institute -
Dr.
David Wata
Pharmacist
Kenyatta National Hospital -
Prof.
Fredrick Chite
Medical Oncologist
International Cancer Institute